Results 181 to 190 of about 9,191 (255)

AS01_B-, MF59-, and alum-based adjuvants and HIV vaccine immunogenicity: a <i>post-hoc</i> cross-protocol comparison of results from HVTN 100, 107, 120, and 702. [PDF]

Front Immunol
Menezes F, Chen S, Grunenberg N, Malahleha M, Mngadi K, Muyoyeta M, Laher F, Chirenje ZM, Bekker LG, Goepfert P, Gray GE, Tomaras G, McElrath MJ, Kallas E, Roxby AC, Moodie Z.   +15 more
europepmc   +1 more source

Optimizing Excipient Properties to Prevent Aggregation in Biopharmaceutical Formulations. [PDF]

J Chem Inf Model
King TE, Humphrey JR, Laughton CA, Thomas NR, Hirst JD.   +4 more
europepmc   +1 more source

Effect of surfactants and polymer composition on the characteristics of polyhydroxyalkanoate nanoparticles. [PDF]

ADMET DMPK
Dorokhin A, Lipaikin S, Ryltseva G, Shabanov A, Sapozhnikova K, Volova T, Kachin S, Shishatskaya E.   +7 more
europepmc   +1 more source

Temperature and excipient mediated modulation of monoclonal antibody interactions revealed by <i>k</i>D, rheology, and Raman spectroscopy. [PDF]

MAbs
Eskens ON, Virk SS, Virk AS, Venkataramani D, Crames M, Vaca MC, Matusewicz M, Smith C, George J, Taylor C, Marlow MS, Amin S.   +11 more
europepmc   +1 more source

Immediate allergic hypersensitivity reactions (anaphylactic shock) to intramuscular dexamethasone in an asthmatic child: a case report. [PDF]

J Med Case Rep
Mahrous R, Mahrous W, Mahrous M.
europepmc   +1 more source

Mitigation Strategies against Antibody Aggregation Induced by Oleic Acid in Liquid Formulations. [PDF]

Mol Pharm
Zürcher D, Wuchner K, Arosio P.
europepmc   +1 more source

Developing high-concentration monoclonal antibody formulations for subcutaneous administration to improve patient treatment. [PDF]

Biophys Rev
Mijangos LRR, Harding SE, Darton NJ.
europepmc   +1 more source

Complexing Protein-Free Botulinum Neurotoxin A Formulations: Implications of Excipients for Immunogenicity. [PDF]

Toxins (Basel)
Martin MU, Frevert J, Tay CM.
europepmc   +1 more source

Nanoparticulate protectants for the dry storage of protein therapeutics. [PDF]

Nanomedicine (Lond)
Park J, Resende MFR, Hudalla GA.
europepmc   +1 more source

New Gel Approaches for the Transdermal Delivery of Meloxicam. [PDF]

Gels
Plugariu IA, Bercea M, Gradinaru LM.
europepmc   +1 more source